CHAPTER 1. Industry Overview of Hydrogel-Based Drug Delivery System Market
1.1. Definition and Scope
1.1.1. Definition of Hydrogel-Based Drug Delivery System
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Hydrogel-Based Drug Delivery System Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Hydrogel-Based Drug Delivery System Market By Polymer Origin
1.2.3. Hydrogel-Based Drug Delivery System Market By Delivery Route
1.2.4. Hydrogel-Based Drug Delivery System Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Hydrogel-Based Drug Delivery System Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Hydrogel-Based Drug Delivery System Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Hydrogel-Based Drug Delivery System Market By Polymer Origin
4.1. Introduction
4.2. Hydrogel-Based Drug Delivery SystemRevenueBy Polymer Origin
4.2.1. Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast, By Polymer Origin, 2018-2030
4.2.2. Synthetic
4.2.2.1. SyntheticMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
4.2.3. Natural
4.2.3.1. Natural Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
4.2.4. Hybrid
4.2.4.1. Hybrid Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 5. Hydrogel-Based Drug Delivery System Market By Delivery Route
5.1. Introduction
5.2. Hydrogel-Based Drug Delivery System Revenue(US$ Mn) By Delivery Route
5.2.1. Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast, By Delivery Route, 2018-2030
5.2.2. Subcutaneous
5.2.2.1. Subcutaneous Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.3. Oral Cavity
5.2.3.1. Oral CavityMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.4. Ocular
5.2.4.1. Ocular Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.5. Topical
5.2.5.1. Topical Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.6. Others
5.2.6.1. OthersMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 6. North America Hydrogel-Based Drug Delivery System Market By Country
6.1. North America Hydrogel-Based Drug Delivery SystemOverview
6.2. U.S.
6.2.1. U.S. Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
6.2.2. U.S. Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
6.3. Canada
6.3.1. Canada Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
6.3.2. Canada Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
6.4. North America PEST Analysis
CHAPTER 7. Europe Hydrogel-Based Drug Delivery System Market By Country
7.1. Europe Hydrogel-Based Drug Delivery SystemOverview
7.2. U.K.
7.2.1. U.K.Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
7.2.2. U.K. Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
7.3. Germany
7.3.1. Germany Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
7.3.2. Germany Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
7.4. France
7.4.1. France Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
7.4.2. France Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
7.5. Spain
7.5.1. Spain Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
7.5.2. Spain Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
7.6. Rest of Europe
7.6.1. Rest of Europe Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
7.6.2. Rest of Europe Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
7.7. Europe PEST Analysis
CHAPTER 8. Asia Pacific Hydrogel-Based Drug Delivery System Market By Country
8.1. Asia Pacific Hydrogel-Based Drug Delivery SystemOverview
8.2. China
8.2.1. China Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
8.2.2. China Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
8.3. Japan
8.3.1. Japan Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
8.3.2. Japan Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
8.4. India
8.4.1. India Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
8.4.2. India Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
8.5. Australia
8.5.1. Australia Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
8.5.2. Australia Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
8.6. South Korea
8.6.1. South Korea Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
8.6.2. South Korea Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
8.7. Rest of Asia-Pacific
8.7.1. Rest of Asia-PacificHydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
8.7.2. Rest of Asia-Pacific Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
8.8. Asia Pacific PEST Analysis
CHAPTER 9. Latin America Hydrogel-Based Drug Delivery System Market By Country
9.1. Latin AmericaHydrogel-Based Drug Delivery SystemOverview
9.2. Brazil
9.2.1. Brazil Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
9.2.2. Brazil Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
9.3. Mexico
9.3.1. MexicoHydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
9.3.2. Mexico Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
9.4. Rest of Latin America
9.4.1. Rest of Latin AmericaHydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
9.4.2. Rest of Latin America Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
9.5. Latin America PEST Analysis
CHAPTER 10. Middle East & Africa Hydrogel-Based Drug Delivery System Market By Country
10.1. Middle East & Africa Hydrogel-Based Drug Delivery SystemOverview
10.2. GCC
10.2.1. GCCHydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
10.2.2. GCC Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
10.3. South Africa
10.3.1. South AfricaHydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
10.3.2. South Africa Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
10.4. Rest of Middle East & Africa
10.4.1. Rest of Middle East & AfricaHydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Polymer Origin, 2018-2030
10.4.2. Rest of Middle East & Africa Hydrogel-Based Drug Delivery System Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
10.5. Middle East & Africa PEST Analysis
CHAPTER 11. Player Analysis Of Hydrogel-Based Drug Delivery System Market
11.1. Hydrogel-Based Drug Delivery System MarketCompany Share Analysis
11.2. Competition Matrix
11.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
11.2.2. New Product Launches and Product Enhancements
11.2.3. Mergers And Acquisition InGlobal Hydrogel-Based Drug Delivery System Market
11.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 12. Company Profile
12.1. Ashland
12.1.1. Company Snapshot
12.1.2. Business Overview
12.1.3. Financial Overview
12.1.3.1. Revenue (US$ Mn), 2021
12.1.3.2. Ashland 2021 Hydrogel-Based Drug Delivery SystemBusiness Regional Distribution
12.1.4. Product/Service and Specification
12.1.5. Recent Developments & Business Strategy
12.1.6. Manufacturing Plant Footprint Analysis
12.2. Bausch and Lomb
12.3. Johnson & Johnson
12.4. Micropore Technologies
12.5. Medtronic
12.6. Neurelis, Inc.
12.7. Ocular Therapeutix, Inc
12.8. ProLynx Inc.
12.9. Pfizer, Inc.
12.10. Teva Pharmaceutical Industries Ltd.
The estimated value of global hydrogel-based drug delivery system market in 2021 was accounted to be USD 6,415 Mn.
The projected CAGR of hydrogel-based drug delivery system market during the analysis period of 2022 to 2030 is 7.6%.
The prominent players of the global hydrogel-based drug delivery system market involve include Ashland, Bausch and Lomb, Johnson & Johnson, Micropore Technologies, Medtronic, Neurelis, Inc., Ocular Therapeutix, Inc, ProLynx Inc., Pfizer, Inc., and Teva Pharmaceutical Industries Ltd.
North America held the dominating share for hydrogel-based drug delivery system during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for hydrogel-based drug delivery system during the analysis period of 2022 to 2030.
High drug loading capacity, easiness of manufacture and self-application quality, and rise in demand for controlled release drug delivery systems drives the growth of global hydrogel-based drug delivery system market.
Based on polymer origin, natural segment held the maximum share for hydrogel-based drug delivery system market in 2021.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date